Chimeric Therapeutics
A clinical stage cell therapy company focused on bringing the promise of cell therapy to life for patients with cancer.
HQ location
Sydney, Australia
Founding location
Melbourne, Australia
Website
Launch date
Employees
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | AUD2.5m | Post IPO Debt | |
| Total Funding | 000k | ||
| AUD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 98804 % | 72 % | 66 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (570869 %) | (492 %) | (525 %) | (150 %) |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (571191 %) | (559 %) | (566 %) | (168 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 142796 % | 198 % | 299 % | 123 % |
Source: Company filings or news article
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.